Results 21 to 30 of about 3,612 (170)
Theranostics, 2021 Rationale: Idiopathic asthenozoospermia (iAZS) is one of the major causes of male infertility and has no effective therapeutic treatment. Understanding the potential mechanisms that cause it may be helpful in seeking novel targets and treatment strategies for overcoming the problem of low sperm motility in iAZS individuals.
Jin, Zi-Run +6 more
openaire +2 more sources
EBioMedicine, 2023 Summary: Background: Asthenozoospermia is the primary cause of male infertility; however, its genetic aetiology remains poorly understood. Adenylate kinase 9 (AK9) is highly expressed in the testes of humans and mice and encodes a type of adenosine ...
Yanwei Sha +10 more
doaj +1 more source
Melatonin ameliorates cisplatin-induced asthenozoospermia via reducing oxidative stress [PDF]
Journal of Men's Health, 2021 Background and objective: Cisplatin is an alkylating agent that has become a first-line therapy for some tumors. However, overproduction of reactive oxygen species (ROS) by cisplatin can cause male infertility, which can affect patients’ quality of ...
Yunpeng Shao +5 more
doaj +1 more source
Proteomic profile of human spermatozoa in healthy and asthenozoospermic individuals
Reproductive Biology and Endocrinology, 2018 Asthenozoospermia is considered as a common cause of male infertility and characterized by reduced sperm motility. However, the molecular mechanism that impairs sperm motility remains unknown in most cases.
Xiaodan Cao +6 more
doaj +1 more source
Біологічні студії, 2022 Background. Analysis of the causes of infertility revealed an increase in the proportion of male factors over the past 20 years by an average of 10–12 %.
A. V. Tarnovska, A. B. Heneha
doaj +1 more source
Treatment of Asthenozoospermia by Intratesticular Testosterone Therapy [PDF]
Archives of Andrology, 1983 A single intratesticular injection of 0.5 cc of 50 mg/ml of an aqueous testosterone suspension was administered to 14 patients with asthenozoospermia. In 7 cases, injection was combined with ultrasound of 0.5 w/cm2 for 2 min weekly for 4 weeks. In another 4 cases, only ultrasound was applied.
M S, Fahim +4 more
openaire +2 more sources
Nutraceutical management of male infertility-towards new generation therapeutics
Journal of Ideas in Health, 2021 Infertility is one of the most significant public health-related concerns globally. Both male and female factors can cause it. Male factors include poor sperm quality, idiopathic oligospermia, asthenozoospermia, and isolated asthenozoospermia.
Olabode Ekerin, Calistus Okechukwu K.
doaj +1 more source
Absolute asthenozoospermia and ICSI: what are the options? [PDF]
Human Reproduction Update, 2011 Complete asthenozoospermia, i.e. 100% immotile spermatozoa in the ejaculate, is reported at a frequency of 1 of 5000 men. Its diagnosis implies a poor fertility prognosis even with ICSI. It is extremely important to distinguish between two different groups of patients with complete asthenozoospermia, i.e. virtual or absolute asthenozoospermia. With the
Ortega, Carolina +5 more
openaire +4 more sources
Acupuncture for oligospermia and asthenozoospermia
Medicine, 2021 Abstract Background: Acupuncture is widely used for oligospermia and asthenozoospermia in China, but its effect is unclear. We aimed to determine the effectiveness and safety of acupuncture in treating oligospermia and asthenozoospermia.
Wen Jia, Chuan Wang, Ying Yin
openaire +2 more sources
Current Issues in Molecular Biology, 2022 Zinc (in the form of Zn2+) is necessary for male fertility. Both Zn2+ quantity and its localisation have been detected in seminal plasma and ejaculated spermatozoa, suggesting its active uptake via zinc import transporters (ZIPs).
Isidora Protic +4 more
doaj +1 more source